Publication | Closed Access

Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement

Hematological MalignancyTumor BiologyCd138 Positive CellsMalignant Blood DisorderImmunologyHematologyMyeloma PatientsImmunomagnetic EnrichmentMedicineCell BiologyTumor MicroenvironmentCancer ResearchMyeloid Neoplasia